612 related articles for article (PubMed ID: 26730646)
1. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
7. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
[TBL] [Abstract][Full Text] [Related]
8. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of hydroxy-safflor yellow A on human umbilical vein endothelial cell apoptosis induced by angiotensin II].
Liu YG; Li FJ
Zhong Yao Cai; 2013 Jul; 36(7):1128-31. PubMed ID: 24417152
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
13. Topical application of Hydroxysafflor Yellow A accelerates the wound healing in streptozotocin induced T1DM rats.
Gao SQ; Chang C; Niu XQ; Li LJ; Zhang Y; Gao JQ
Eur J Pharmacol; 2018 Mar; 823():72-78. PubMed ID: 29408092
[TBL] [Abstract][Full Text] [Related]
14. Eupolyphaga sinensis Walker demonstrates angiogenic activity and inhibits A549 cell growth by targeting the KDR signaling pathway.
Dai B; Qi J; Liu R; Zhang Y
Mol Med Rep; 2014 Sep; 10(3):1590-6. PubMed ID: 25059654
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
[TBL] [Abstract][Full Text] [Related]
17. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
19. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
20. Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways.
Zhao J; Zhao L; Chen W; He L; Li X
Biomed Pharmacother; 2008; 62(6):383-9. PubMed ID: 17826025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
